Research Papers

23 of 1048 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Relating circulating thyroid hormone concentrations to serum interleukins-6 and -10 in association with non-thyroidal i…
Abo-Zenah HA; Shoeb SA; Sabry AA; Ismail HA.
BMC Endocr Disord (Unknown)
Published: 2008
1/6 Transparent
Study Protocol: insulin and its role in cancer.
Harish K; Dharmalingam M; Himanshu M.
BMC Endocr Disord (Unknown)
Published: 2007
2/6 Transparent
Funding Declared
Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas.
Costa-Guda J; Tokura T; Roth SI; Arnold A.
BMC Endocr Disord (Unknown)
Published: 2007
2/6 Transparent
Funding Declared
Brief Intervention in Type 1 diabetes - Education for Self-efficacy (BITES): Protocol for a randomised control trial to…
George JT; Valdovinos AP; Thow JC; Russell I; Dromgoole P; Lomax S; Torgerson DJ; Wells T.
BMC Endocr Disord (Unknown)
Published: 2007
3/6 Transparent
Registered Funding Declared
Diagnostic accuracy of basal TSH determinations based on the intravenous TRH stimulation test: an evaluation of 2570 te…
Moncayo H; Dapunt O; Moncayo R.
BMC Endocr Disord (Unknown)
Published: 2007
1/6 Transparent
Is annual surveillance of all treated hypothyroid patients necessary?
Viswanath AK; Avenell A; Philip S; Acharya SH; Maclennan G; Dalziel K; Pereira O; Copland SA; Bevan JS; Abraham P.
BMC Endocr Disord (Unknown)
Published: 2007
2/6 Transparent
Funding Declared
Accuracy of self-reported height measurements in parents and its effect on mid-parental target height calculation.
Braziuniene I; Wilson TA; Lane AH.
BMC Endocr Disord (Unknown)
Published: 2007
2/6 Transparent
Funding Declared
A multinodular goiter as the initial presentation of a renal cell carcinoma harbouring a novel VHL mutation.
Bugalho MJ; Mendonça E; Costa P; Santos JR; Silva E; Catarino AL; Sobrinho LG.
BMC Endocr Disord (Unknown)
Published: 2006
2/6 Transparent
Funding Declared
Understanding and meeting the needs of those using growth hormone injection devices.
Dumas H; Panayiotopoulos P; Parker D; Pongpairochana V.
BMC Endocr Disord (Unknown)
Published: 2006
2/6 Transparent
Funding Declared
Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study.
Onady GM; Langdon LJ.
BMC Endocr Disord (Unknown)
Published: 2006
2/6 Transparent
Funding Declared
Reversible hypothyroidism and Whipple's disease.
Tran HA.
BMC Endocr Disord (Unknown)
Published: 2006
1/6 Transparent
Neurocognitive function in children with compensated hypothyroidism: lack of short term effects on or off thyroxin.
Aijaz NJ; Flaherty EM; Preston T; Bracken SS; Lane AH; Wilson TA.
BMC Endocr Disord (Unknown)
Published: 2006
2/6 Transparent
Funding Declared
The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-alpha2b…
Tran HA; Jones TL; Batey RG.
BMC Endocr Disord (Unknown)
Published: 2005
1/6 Transparent
Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North Indians: a case control study.
Dixit M; Bhattacharya S; Mittal B.
BMC Endocr Disord (Unknown)
Published: 2005
2/6 Transparent
Funding Declared
Effects of aging and type 2 diabetes on resting and post occlusive hyperemia of the forearm; the impact of rosiglitazon…
Petrofsky J; Lee S; Cuneo M.
BMC Endocr Disord (Unknown)
Published: 2005
2/6 Transparent
Funding Declared
Discordance in diagnosis of osteoporosis using spine and hip bone densitometry.
Moayyeri A; Soltani A; Tabari NK; Sadatsafavi M; Hossein-Neghad A; Larijani B.
BMC Endocr Disord (Unknown)
Published: 2005
1/6 Transparent
Nutrient-stimulated insulin secretion in mouse islets is critically dependent on intracellular pH.
Gunawardana SC; Rocheleau JV; Head WS; Piston DW.
BMC Endocr Disord (Unknown)
Published: 2004
2/6 Transparent
Funding Declared
Randomised prospective study for the effect of therapy on residual beta cell function in type-1 diabetes mellitus [ISRC…
Linn T; Mann M; Mann M; Bretzel RG; Boedeker RH.
BMC Endocr Disord (Unknown)
Published: 2003
Glucagon-like peptide 1 improved glycemic control in type 1 diabetes.
Behme MT; Dupré J; McDonald TJ.
BMC Endocr Disord (Unknown)
Published: 2003
1/6 Transparent
Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after renal transplantation in the United States.
Abbott KC; Bernet VJ; Agodoa LY; Yuan CM.
BMC Endocr Disord (Unknown)
Published: 2003
1/6 Transparent
Tyrosine hydroxylase activity in the endocrine pancreas: changes induced by short-term dietary manipulation.
Borelli MI; Rubio M; García ME; Flores LE; Gagliardino JJ.
BMC Endocr Disord (Unknown)
Published: 2003
2/6 Transparent
Funding Declared
Treatment of hyperfunctioning thyroid nodules by percutaneous ethanol injection.
Larijani B; Pajouhi M; Ghanaati H; Bastanhagh MH; Abbasvandi F; Firooznia K; Shirzad M; Amini MR; Sarai M; Abbasvandi N; Baradar-Jalili R.
BMC Endocr Disord (Unknown)
Published: 2002
1/6 Transparent
Diagnostic criteria for diabetes revisited: making use of combined criteria.
Parappil A; Doi SA; Al-Shoumer KA.
BMC Endocr Disord (Unknown)
Published: 2002
1/6 Transparent